These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7383888)

  • 1. [Level of platelet malonaldehyde in diabetics].
    Stoltz JF; Voisin P; Genisti G; Drouin P; Pointel JP; Vernhes G
    Nouv Presse Med; 1980 Jan; 9(4):250. PubMed ID: 7383888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formation of platelet malondialdehyde in hypertensive patients subjected to cycloergometric exercise tests].
    Davì G; Novo S; Riolo F; Pinto A; Mendola G; Mazzola A; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(10):1167-72. PubMed ID: 7326120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of a method of determining the concentration of malondialdehyde in the formed elements of the blood to predicting the course of ophthalmoherpes].
    Dalgat LD; Kasavina BS; Maĭchuk IuF
    Oftalmol Zh; 1981; 36(8):489-90. PubMed ID: 7335282
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet malondialdehyde and plasma thromboxane B2 formation in patients with obliterative arteriosclerosis of the lower limbs.
    Bodzenta A; Bielawiec M; Krupiński K; Wojtukiewicz M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):804-7. PubMed ID: 6188668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of temperature and preservation time on the aggregation and MDA level of blood platelets].
    Stachecki B; Kaszkowiak M; Kotelba-Witkowska B; Jakuboszczak E; Fenrych W
    Acta Haematol Pol; 1986; 17(3-4):122-30. PubMed ID: 3591238
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet malonyldialdehyde formation: an indicator of platelet hyperfunction.
    Stuart MJ
    Thromb Haemost; 1979 Aug; 42(2):649-54. PubMed ID: 505371
    [No Abstract]   [Full Text] [Related]  

  • 8. Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation.
    Torsellini A; Doni L; Palinski W; Guidi G; Lombardi V
    Thromb Haemost; 1984 Aug; 52(1):4-6. PubMed ID: 6238444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet malonyldialdehyde and spontaneous aggregation during ischaemic attacks of patients with polycythaemia vera.
    Cortelazzo S; Barbui T; Viero P; Bassan R; Dini E; Ferro Milone F
    Thromb Haemost; 1979 Dec; 42(4):1344-6. PubMed ID: 542939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oxygen consumption, release reaction and formation of malondialdehyde in the platelets of newborn infants following addition of thrombin].
    Del Principe D; Damiano AM; Mastracchio F; Corrado G; Menichelli A; Negrini R
    Minerva Pediatr; 1978 Jul; 30(14):1153-6. PubMed ID: 672858
    [No Abstract]   [Full Text] [Related]  

  • 11. Malondialdehyde production and the release reaction in rat blood platelets: inhibition by aspirin and indomethacin ex vivo [proceedings].
    Gordon JL; MacIntyre DE; McMillan RM
    Br J Pharmacol; 1976 Oct; 58(2):299P-300P. PubMed ID: 974415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optimization of a method for determining platelet malondialdehyde production].
    Parise P; Berrettini M; Nenci GG
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1502-8. PubMed ID: 6318783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
    Sullivan JM; Taylor JC; Samaha JK
    Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ratio MDA/MDAa as a new index of platelet hyperactivity.
    Makris PE; Tsakiris DA; Papadopoulos A; Ballas A
    Haemostasis; 1985; 15(5):331-6. PubMed ID: 4076840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
    Rajtar G; Livio M; Merino J; de Gaetano G
    Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory diagnostic monitoring of individually dosed antithrombotic therapy with acetylsalicylic acid in patients with atherosclerosis].
    Misselwitz F; Norden C
    Z Med Lab Diagn; 1989; 30(1):43-4. PubMed ID: 2718577
    [No Abstract]   [Full Text] [Related]  

  • 17. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro.
    Livio M; Rajtar G; Merino J; de Gaetano G
    Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet regeneration time: a statistical approach.
    Lopes AA; Maeda NY; Chamone DA; Sauaia N
    Braz J Med Biol Res; 1988; 21(3):471-3. PubMed ID: 3228627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic toxins inhibit the platelet malonyldialdehyde production rate.
    Tanaka H; Itoh S; Yamagami S; Kishimoto T; Maekawa M; Ringoir S
    Adv Exp Med Biol; 1987; 223():115-8. PubMed ID: 3447425
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma malonaldehyde levels during myocardial infarction.
    Dousset JC; Trouilh M; Foglietti MJ
    Clin Chim Acta; 1983 Apr; 129(3):319-22. PubMed ID: 6851170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.